{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:13:33Z","timestamp":1770905613320,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"DOI":"10.1038\/s41371-025-01105-6","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T15:36:17Z","timestamp":1764862577000},"page":"103-109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of apparent treatment-resistant hypertension and screening rates for primary aldosteronism in an asian ambulatory care setting"],"prefix":"10.1038","volume":"40","author":[{"given":"Tanawin","family":"Suksiriworaboot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Yacharad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1294-7800","authenticated-orcid":false,"given":"Weerapat","family":"Kositanurit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongkasem","family":"Vorasettakarnkij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarat","family":"Sunthornyothin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apichard","family":"Sukonthasarn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pairoj","family":"Chattranukulchai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"1105_CR1","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","volume":"72","author":"RM Carey","year":"2018","unstructured":"Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, et al. Resistant hypertension: detection, evaluation, and management: a scientific statement from the American heart association. Hypertension. 2018;72:e53\u2013e90.","journal-title":"Hypertension"},{"key":"1105_CR2","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020;75:1334\u201357.","journal-title":"Hypertension"},{"key":"1105_CR3","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.35755\/jmedassocthai.2021.10.12199","volume":"104","author":"S Kunanon","year":"2021","unstructured":"Kunanon S, Chattranukulchai P, Chotruangnapa C, Kositanurit W, Methavigul K, Boonyasirinant T, et al. 2019 Thai guidelines on the treatment of hypertension: executive summary. J Med Assoc Thai. 2021;104:1729\u201338.","journal-title":"J Med Assoc Thai"},{"key":"1105_CR4","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European society of hypertension: endorsed by the international society of hypertension (ISH) and the European renal association (ERA). J Hypertens. 2023;41:1874\u20132071.","journal-title":"J Hypertens"},{"key":"1105_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/ajh\/hpu151","volume":"28","author":"D Achelrod","year":"2015","unstructured":"Achelrod D, Wenzel U, Frey S. Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations. Am J Hypertens. 2015;28:355\u201361.","journal-title":"Am J Hypertens"},{"key":"1105_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.pcad.2019.12.006","volume":"63","author":"R Chia","year":"2020","unstructured":"Chia R, Pandey A, Vongpatanasin W. Resistant hypertension-defining the scope of the problem. Prog Cardiovasc Dis. 2020;63:46\u201350.","journal-title":"Prog Cardiovasc Dis"},{"key":"1105_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3261408","volume":"2020","author":"S Montrivade","year":"2020","unstructured":"Montrivade S, Chattranukulchai P, Siwamogsatham S, Vorasettakarnkij Y, Naeowong W, Boonchayaanant P, et al. Hypertension subtypes among Thai hypertensives: an analysis of telehealth-assisted instrument in home blood pressure monitoring nationwide pilot project. Int J Hypertens. 2020;2020:3261408.","journal-title":"Int J Hypertens"},{"key":"1105_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M20-0065","volume":"173","author":"JM Brown","year":"2020","unstructured":"Brown JM, Siddiqui M, Calhoun DA, Carey RM, Hopkins PN, Williams GH, et al. The unrecognized prevalence of primary aldosteronism: a cross-sectional study. Ann Intern Med. 2020;173:10\u201320.","journal-title":"Ann Intern Med"},{"key":"1105_CR9","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","volume":"18","author":"AF Turcu","year":"2022","unstructured":"Turcu AF, Yang J, Vaidya A. Primary aldosteronism - a multidimensional syndrome. Nat Rev Endocrinol. 2022;18:665\u201382.","journal-title":"Nat Rev Endocrinol"},{"key":"1105_CR10","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1210\/clinem\/dgaa606","volume":"105","author":"A Vaidya","year":"2020","unstructured":"Vaidya A, Carey RM. Evolution of the primary aldosteronism syndrome: updating the approach. J Clin Endocrinol Metab. 2020;105:3771\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"1105_CR11","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1161\/HYPERTENSIONAHA.119.14063","volume":"75","author":"J Burrello","year":"2020","unstructured":"Burrello J, Monticone S, Losano I, Cavaglia G, Buffolo F, Tetti M, et al. Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit. Hypertension. 2020;75:1025\u201333.","journal-title":"Hypertension"},{"key":"1105_CR12","first-page":"2854","volume":"85","author":"KC Loh","year":"2000","unstructured":"Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young WF Jr. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab. 2000;85:2854\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"1105_CR13","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","volume":"75","author":"Z Xu","year":"2020","unstructured":"Xu Z, Yang J, Hu J, Song Y, He W, Luo T, et al. Primary aldosteronism in patients in china with recently detected hypertension. J Am Coll Cardiol. 2020;75:1913\u201322.","journal-title":"J Am Coll Cardiol"},{"key":"1105_CR14","doi-asserted-by":"publisher","first-page":"e212","DOI":"10.1161\/HYP.0000000000000257","volume":"82","author":"DW Jones","year":"2025","unstructured":"Jones DW, Ferdinand KC, Taler SJ, Johnson HM, Shimbo D, Abdalla M, et al. 2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. Hypertension. 2025;82:e212\u2013e316.","journal-title":"Hypertension"},{"key":"1105_CR15","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","volume":"110","author":"GK Adler","year":"2025","unstructured":"Adler GK, Stowasser M, Correa RR, Khan N, Kline G, McGowan MJ, et al. Primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2025;110:2453\u201395.","journal-title":"J Clin Endocrinol Metab"},{"key":"1105_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.7326\/M20-4873","volume":"174","author":"JB Cohen","year":"2021","unstructured":"Cohen JB, Cohen DL, Herman DS, Leppert JT, Byrd JB, Bhalla V. Testing for primary aldosteronism and mineralocorticoid receptor antagonist use among U.S. Veterans : a retrospective cohort study. Ann Intern Med. 2021;174:289\u201397.","journal-title":"Ann Intern Med"},{"key":"1105_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1161\/HYPERTENSIONAHA.121.18118","volume":"79","author":"GL Hundemer","year":"2022","unstructured":"Hundemer GL, Imsirovic H, Vaidya A, Yozamp N, Goupil R, Madore F, et al. Screening rates for primary aldosteronism among individuals with hypertension plus hypokalemia: a population-based retrospective cohort study. Hypertension. 2022;79:178\u201386.","journal-title":"Hypertension"},{"key":"1105_CR18","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1038\/s41440-024-01785-6","volume":"47","author":"P Chattranukulchai","year":"2024","unstructured":"Chattranukulchai P, Roubsanthisuk W, Kunanon S, Kotruchin P, Satirapoj B, Wongpraparut N, et al. Resistant hypertension: diagnosis, evaluation, and treatment a clinical consensus statement from the Thai hypertension society. Hypertens Res. 2024;47:2447\u201355.","journal-title":"Hypertens Res"},{"key":"1105_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1471-2296-15-131","volume":"15","author":"YC Chia","year":"2014","unstructured":"Chia YC, Ching SM. Prevalence and predictors of resistant hypertension in a primary care setting: a cross-sectional study. BMC Fam Pract. 2014;15:131.","journal-title":"BMC Fam Pract"},{"key":"1105_CR20","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ihj.2017.01.012","volume":"69","author":"R Naseem","year":"2017","unstructured":"Naseem R, Adam AM, Khan F, Dossal A, Khan I, Khan A, et al. Prevalence and characteristics of resistant hypertensive patients in an Asian population. Indian Heart J. 2017;69:442\u20136.","journal-title":"Indian Heart J"},{"key":"1105_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8844727","volume":"2021","author":"A Sakulsupsiri","year":"2021","unstructured":"Sakulsupsiri A, Chattranukulchai P, Siwamogsatham S, Boonchayaanant P, Naeowong W, Ariyachaipanich A, et al. Home blood pressure control and drug prescription patterns among Thai hypertensives: a 1-year analysis of telehealth assisted instrument in home blood pressure monitoring nationwide pilot project. Int J Hypertens. 2021;2021:8844727.","journal-title":"Int J Hypertens"},{"key":"1105_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.eprac.2021.11.085","volume":"28","author":"K Zekarias","year":"2022","unstructured":"Zekarias K, Tessier KM. Screening rate for primary aldosteronism among patients with apparent treatment-resistant hypertension: retrospective analysis of current practice. Endocr Pract. 2022;28:271\u20135.","journal-title":"Endocr Pract"},{"key":"1105_CR23","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.119.14359","volume":"75","author":"G Jaffe","year":"2020","unstructured":"Jaffe G, Gray Z, Krishnan G, Stedman M, Zheng Y, Han J, et al. Screening rates for primary aldosteronism in resistant hypertension: a cohort study. Hypertension. 2020;75:650\u20139.","journal-title":"Hypertension"},{"key":"1105_CR24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.025952","volume":"11","author":"AF Turcu","year":"2022","unstructured":"Turcu AF, Nhan W, Grigoryan S, Zhang L, Urban C, Liu H, et al. Primary aldosteronism screening rates differ with sex, race, and comorbidities. J Am Heart Assoc. 2022;11:e025952.","journal-title":"J Am Heart Assoc"},{"key":"1105_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1053\/j.ajkd.2023.01.447","volume":"82","author":"M Funes Hernandez","year":"2023","unstructured":"Funes Hernandez M, Bhalla V. Underdiagnosis of primary aldosteronism: a review of screening and detection. Am J Kidney Dis. 2023;82:333\u201346.","journal-title":"Am J Kidney Dis"},{"key":"1105_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.036373","volume":"13","author":"W Kositanurit","year":"2024","unstructured":"Kositanurit W, Giacona JM, Xie D, Wang J, Feuer D, O\u2019Malley KJ, et al. Trends in primary aldosteronism screening among high-risk hypertensive adults. J Am Heart Assoc. 2024;13:e036373.","journal-title":"J Am Heart Assoc"},{"key":"1105_CR27","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/fampra\/cmae033","volume":"41","author":"K Tsan","year":"2024","unstructured":"Tsan K, Yang J, Nainani A, Libianto R, Russell G. Screening for primary aldosteronism in primary care: a scoping review. Fam Pract. 2024;41:851\u20136.","journal-title":"Fam Pract"},{"key":"1105_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-07788-8","volume":"22","author":"O Suntornlohanakul","year":"2022","unstructured":"Suntornlohanakul O, Sakarin S, Kietsiriroje N, Sriplung H. Geographical inequality in service utilization for primary aldosteronism screening: spatial epidemiological study in Southern Thailand. BMC Health Serv Res. 2022;22:458.","journal-title":"BMC Health Serv Res"},{"key":"1105_CR29","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1161\/HYPERTENSIONAHA.121.17444","volume":"78","author":"F Buffolo","year":"2021","unstructured":"Buffolo F, Burrello J, Burrello A, Heinrich D, Adolf C, M\u00fcller LM, et al. Clinical score and machine learning-based model to predict diagnosis of primary aldosteronism in arterial hypertension. Hypertension. 2021;78:1595\u2013604.","journal-title":"Hypertension"},{"key":"1105_CR30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/jamainternmed.2023.7389","volume":"184","author":"S Charoensri","year":"2024","unstructured":"Charoensri S, Bashaw L, Dehmlow C, Ellies T, Wyckoff J, Turcu AF. Evaluation of a best-practice advisory for primary aldosteronism screening. JAMA Intern Med. 2024;184:174\u201382.","journal-title":"JAMA Intern Med"},{"key":"1105_CR31","doi-asserted-by":"publisher","first-page":"e1574","DOI":"10.1210\/clinem\/dgad752","volume":"109","author":"G Gupta","year":"2024","unstructured":"Gupta G, Teo AED, Swee DS, Loh LM, Chuah M, Loh WJ, et al. Prolonged hypokalemia and delayed diagnosis of primary aldosteronism: clinical course and risk factors. J Clin Endocrinol Metab. 2024;109:e1574\u2013e81.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01105-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01105-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01105-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:22:37Z","timestamp":1770902557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01105-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["1105"],"URL":"https:\/\/doi.org\/10.1038\/s41371-025-01105-6","relation":{},"ISSN":["1476-5527"],"issn-type":[{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}